Acid/light dual-responsive biodegradable polymeric nanocarriers for efficient intracellular drug delivery

被引:0
作者
Yuanyuan Zhang
Xiang Cao
Tian Liang
Zhiwei Tong
机构
[1] Huaihai Institute of Technology,Jiangsu Key Laboratory of Function Control Technology for Advanced Materials, School of Chemical Engineering
来源
Polymer Bulletin | 2019年 / 76卷
关键词
Block copolymer; Acid/light dual response; Polymeric nanoparticles; Drug delivery;
D O I
暂无
中图分类号
学科分类号
摘要
A novel amphiphilic acid/light dual-cleavable diblock copolymer poly(ε-caprolactone)-acetal-nitrobenzyl ester-poly(ethylene glycol) (PCL-PEG) was prepared via the ring-opening polymerization of ε-caprolactone using 5-propargylether-2-nitrobenzyl alcohol as the initiator and subsequent “click” coupling reaction with azide-terminated poly(ethylene glycol) containing acetal group. Both light-cleavable o-nitrobenzyl methyl ester (ONB) and acid-labile acetal were used as the linkages in between the hydrophilic and hydrophobic polymer blocks. In aqueous solution, the copolymer self-assembled into the spherical polymeric nanoparticles, which were stable under physiological conditions and retained the anticancer drug doxorubicin (DOX) inside. Triggered by acid or UV irradiation, the DOX release rate was significantly enhanced, due to the correspondent degradation of acetal or ONB linkages under the stimulus. In addition, confocal laser scanning microscopy studies further demonstrated the DOX-loaded nanodrug could be efficiently taken up by HeLa cells and exhibited the enhanced DOX release into the cytoplasm upon UV irradiation. Furthermore, in vitro cytotoxicity study verified UV irradiation could improve the antitumor efficacy of the nanodrug against HeLa cells. Thus, this work provides a new method of the design of dual-responsive biodegradable polymers for drug delivery.
引用
收藏
页码:1775 / 1792
页数:17
相关论文
共 227 条
[1]  
Davis ME(2008)Nanoparticle therapeutics: an emerging treatment modality for cancer Nat Rev Drug Discov 7 771-782
[2]  
Chen ZG(2014)State-of-the-art in design rules for drug delivery platforms: lessons learned from FDA-approved nanomedicines J Control Release 187 133-144
[3]  
Shin DM(2010)Delivering nanomedicine to solid tumors Nat Rev Clin Oncol 7 653-442
[4]  
Dawidczyk CM(2008)Nanoparticle therapeutics: an emerging treatment modality for cancer Nat Rev Drug Discovery 7 771-670
[5]  
Kim C(2012)Intracellular drug release nanosystems Mater Today 15 436-990
[6]  
Park JH(2015)Bioresponsive polymeric nanotherapeutics for targeted cancer chemotherapy Nano Today 10 656-2154
[7]  
Russell LM(2007)Physical stimuli-responsive polymeric micelles for anti-cancer drug delivery Prog Polym Sci 32 962-167
[8]  
Lee KH(2015)Stimuli-Responsive nanomaterials for biomedical applications J Am Chem Soc 137 2140-907
[9]  
Pomper MG(2016)Mechanisms and biomaterials in pH-responsive tumour targeted drug delivery: a review Biomaterials 85 152-2198
[10]  
Searson PC(2018)Acid-activatable doxorubicin prodrug micelles with folate-targeted and ultra-high drug loading features for efficient antitumor drug delivery J Mater Sci 53 892-7243